http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2014007878-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae10212794160b34478f0d05b6ab6fd7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2826
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2012-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f5e69237af6dfaa50aeaee4572e723f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8d4e2750eae9e5abad202d4d5fbdef5
publicationDate 2015-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2014007878-A
titleOfInvention FORMULATIONS OF (+) - 2 - [1 - (3 - ETOXI - 4 - METOXI - PHENYL) - 2 - METANSULFONIL - ETIL] - 4 - AMINOISOINDOLIN OIL - 1, 3 - DIONA.
abstract Simple pharmaceutical unit compositions and dosage forms of (+) - 2- [1- (3-ethoxy-4-methoxy-phenyl) -2-methanesulfonyl-ethyl] -4-acetylaminoisoindolin-1, 3-dione, or a Prodrug stereoisomer, salt, solvate, hydrate or pharmaceutically acceptable clathrate thereof, is provided herein. Methods for treating, managing, or preventing various diseases or disorders are also provided. The compound is known as Apremilast and has the following structural formula: (see Formula (I)).
priorityDate 2011-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11561674

Total number of triples: 32.